During the past decade, Oxford Centre for Diabetes, Endocrinology and Metabolism conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Oxford Centre for Diabetes, Endocrinology and Metabolism" are "NAFLD" (3 trials), "Acromegaly" (1 trials), "Fat; Liver" (1 trials), "Fatty Acid Oxidation" (1 trials) and "Hypertriglyceridaemia" (1 trials). Many other conditions were trialed in "Oxford Centre for Diabetes, Endocrinology and Metabolism" in a lesser frequency.

Most popular intervention types in "Oxford Centre for Diabetes, Endocrinology and Metabolism" are "Other" (4 trials), "Dietary Supplement" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dietary fatty acid partitioning" (1 trials), "Dietary supplement: fatty acid" (1 trials), "High-fat, low-carbohydrate" (1 trials), "Low-fat, high-carbohydrate" (1 trials) and "Octreotide capsules" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oxford Centre for Diabetes, Endocrinology and Metabolism" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Oxford Centre for Diabetes, Endocrinology and Metabolism". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Oxford Centre for Diabetes, Endocrinology and Metabolism, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oxford Centre for Diabetes, Endocrinology and Metabolism, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".